adamantane has been researched along with Metabolic Syndrome in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aal, M; Abdel-Ghany, RH; Alsemeh, AE; Ghareib, SA; Sabry, D; Wahba, NS | 1 |
| Cao, J; Deng, X; Di, Y; Gao, J; Guo, Y; Huang, X; Liu, L; Sun, S | 1 |
| Boyd, S; deSchoolmeester, J; Dossetter, AG; Goldberg, FW; Groombridge, SD; Gutierrez, PM; Kemmitt, PD; Robb, GR; Scott, JS; Sjögren, T; Swales, JG; Turnbull, AV; Wild, MJ | 1 |
| Choi, CS; Han, HY; Jeong, KH; Jun, HS; Kim, S; Kim, SS; Lee, HJ; Oh, H; Ryu, JH; Sa, JH; Son, HJ | 1 |
| Avogaro, A; de Kreutzenberg, SV; Fadini, GP; Gjini, R | 1 |
| Aerts, JM; Aten, J; Bietrix, FM; Bijl, N; Boot, RG; Dekker, N; Groen, AK; Groener, J; Langeveld, M; Lombardo, E; Ottenhoff, R; Overkleeft, HS; Serlie, M; van Eijk, M; van Roomen, C; Wennekes, T | 1 |
| Aster, SD; Balkovec, JM; Brown, K; Carbin, L; Graham, DW; Hermanowski-Vosatka, A; LeGrand, CB; Mundt, SS; Olson, S; Robbins, MA; Schaeffer, JM; Slossberg, LH; Szymonifka, MJ; Thieringer, R; Wright, SD | 1 |
1 review(s) available for adamantane and Metabolic Syndrome
| Article | Year |
|---|---|
Glycosphingolipids and insulin resistance.
Topics: 1-Deoxynojirimycin; Adamantane; Animals; Cardiovascular Diseases; Ceramides; Diabetes Mellitus, Type 2; Dioxanes; Disease Models, Animal; Fatty Acids; Fatty Liver; Gaucher Disease; Glucosyltransferases; Glycosphingolipids; Humans; Insulin Resistance; Metabolic Syndrome; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Pyrrolidines; Receptor, Insulin; Signal Transduction | 2011 |
1 trial(s) available for adamantane and Metabolic Syndrome
| Article | Year |
|---|---|
The metabolic syndrome influences the response to incretin-based therapies.
Topics: Adamantane; Aged; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon-Like Peptide 1; Humans; Hypoglycemic Agents; Incretins; Male; Metabolic Syndrome; Middle Aged; Nitriles; Peptides; Prognosis; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Treatment Outcome; Triazoles; Venoms; Vildagliptin | 2011 |
5 other study(ies) available for adamantane and Metabolic Syndrome
| Article | Year |
|---|---|
Vitamin D3 potentiates the nephroprotective effects of vildagliptin-metformin combination in a rat model of metabolic syndrome.
Topics: Adamantane; Animals; Cholecalciferol; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Hypoglycemic Agents; Male; Metabolic Syndrome; Metformin; Nitriles; Pyrrolidines; Rats; Rats, Wistar; Vildagliptin | 2022 |
Improved endogenous epoxyeicosatrienoic acid production mends heart function via increased PGC 1α-mitochondrial functions in metabolic syndrome.
Topics: Adamantane; Adenosine Triphosphate; Animals; Cardiotonic Agents; Disease Models, Animal; Endothelium; Fibrosis; Heme Oxygenase-1; Hemodynamics; Hypertrophy; Inflammation Mediators; Lauric Acids; Male; Metabolic Syndrome; Mitochondria; Myocardium; Nitric Oxide Synthase Type III; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats, Wistar; Up-Regulation | 2018 |
Optimization of brain penetrant 11β-hydroxysteroid dehydrogenase type I inhibitors and in vivo testing in diet-induced obese mice.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Animals; Blood Glucose; Body Weight; Brain; Crystallography, X-Ray; Cyclopropanes; Diabetes Mellitus, Type 2; Dietary Fats; Humans; Hypoglycemic Agents; Insulin; Isoenzymes; Liver; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Mice, Obese; Models, Molecular; Pyrazoles; Rats; Stereoisomerism; Structure-Activity Relationship; Thiazoles | 2014 |
A potent and selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, SKI2852, ameliorates metabolic syndrome in diabetic mice models.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Adipose Tissue; Animals; Body Weight; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glycated Hemoglobin; Insulin Resistance; Lipids; Liver; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Pyrimidines | 2015 |
Adamantyl triazoles as selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adamantane; Animals; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Metabolic Syndrome; Mice; Pharmacokinetics; Structure-Activity Relationship; Triazoles | 2005 |